Cargando…
Trimetazidine ameliorates hindlimb ischaemic damage in type 2 diabetic mice
BACKGROUND: Ischaemia caused by lower extremity artery stenosis is the main cause of peripheral artery disease (PAD) in patients with diabetes. Trimetazidine (TMZ) has traditionally been used as an anti-ischaemic drug for coronary artery disease. The effect of TMZ on PAD in a diabetic animal model a...
Autores principales: | Yang, Yan, Xu, Qinqin, Li, Tao, Shao, Shiying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8281072/ https://www.ncbi.nlm.nih.gov/pubmed/34259103 http://dx.doi.org/10.1080/07853890.2021.1925147 |
Ejemplares similares
-
Association of Agenesis of the Dorsal Pancreas With HNF1B Heterozygote Mutation: A Case Report
por: Guo, Mei, et al.
Publicado: (2021) -
Trimetazidine ameliorates sunitinib-induced cardiotoxicity in mice via the AMPK/mTOR/autophagy pathway
por: Yang, Yi, et al.
Publicado: (2019) -
A MEN1 Patient Presenting With Multiple Parathyroid Adenomas and Transient Hypercortisolism: A Case Report and Literature Review
por: Chen, Fuqiong, et al.
Publicado: (2022) -
Sodium Butyrate Ameliorates Streptozotocin-Induced Type 1 Diabetes in Mice by Inhibiting the HMGB1 Expression
por: Guo, Yu, et al.
Publicado: (2018) -
Cardiac Effects of Trimetazidine in Diabetic Rats
por: Mansur, Alfredo J.
Publicado: (2019)